menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Personalized Diagnostics & Targeted Therapies

Program Information
Recommended
Personalized Diagnostics & Targeted Therapies
RestartResume
The Philadelphia Chromosome provided the first evidence that genetic abnormalities were linked to cancer. This discovery at Penn Medicine more than...
  • In Partnership with

  • Overview

    The Philadelphia Chromosome provided the first evidence that genetic abnormalities were linked to cancer. This discovery at Penn Medicine more than 50 years ago ushered in the modern period of cytogenetics. Now, the Center for Personalized Diagnostics (CPD) builds on this legacy and is set to pave the way for a new era of genomic and therapeutic pathology. The Center is a joint initiative with the Abramson Cancer Centerand integrates molecular genetics, pathology informatics and genomic pathology to empower physicians and patients to truly customize their treatment options accordingly. Host Dr. Lee Freedman welcomes Dr. David Roth, Chair of the Department of Pathology and Laboratory Medicine and Simon Flexner Professor of Pathology and Laboratory Medicine at Penn Medicine to discuss the unique Center and offerings for patients.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/19/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.